Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats

Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice

(2018) David Cheng et al.   JOURNAL OF ALZHEIMERS DISEASE

Persistent effect of withdrawal from intravenous methamphetamine self-administration on brain activation and behavioral economic indices involving an effort cost

(2018) Evan E. Hart et al.   NEUROPHARMACOLOGY

Pharmacotherapeutic agents in the treatment of methamphetamine dependence

(2017) Kirsten C. Morley et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

(2017) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors

(2017) T. Bakas et al.   PHARMACOLOGICAL RESEARCH

Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome

(2017) Joshua S. Kaplan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats

(2016) Cristiane Ribeiro de Carvalho et al.   ADDICTION BIOLOGY

Methamphetamine self-administration modulates glutamate neurophysiology

(2016) Devesh Mishra et al.   Brain Structure & Function

Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats

(2016) Ashraf Mahmud et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

(2015) John M McPartland et al.   BRITISH JOURNAL OF PHARMACOLOGY

Neural correlates of interactions between cannabidiol and Δ9-tetrahydrocannabinol in mice: implications for medical cannabis

(2015) S M Todd et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol as a Potential Treatment for Anxiety Disorders

(2015) Esther M. Blessing et al.   Neurotherapeutics

Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats

(2014) Sarah J. Baracz et al.   ADDICTION BIOLOGY

Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings

(2013) Celia J.A. Morgan et al.   ADDICTIVE BEHAVIORS

Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1Areceptors in the dorsal raphe nucleus

(2012) Vicky Katsidoni et al.   ADDICTION BIOLOGY

Extinction-Dependent Alterations in Corticostriatal mGluR2/3 and mGluR7 Receptors following Chronic Methamphetamine Self-Administration in Rats

(2012) Marek Schwendt et al.   PLoS One

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions

(2009) L. Orio et al.   JOURNAL OF NEUROSCIENCE

Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances

(2009) Y. Ren et al.   JOURNAL OF NEUROSCIENCE

Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo

(2009) N. A. Jones et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Fast uptake and long-lasting binding of methamphetamine in the human brain: Comparison with cocaine

(2008) Joanna S. Fowler et al.   NEUROIMAGE

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY